Jasmin Spiegelberg

Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-up

M. Pichler, R. Zigeuner, G. Hutterer, 2022, Therapeutic advances in medical oncology.

Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer Study

A. Gerger, T. Madl, G. Absenger, 2022, Frontiers in Immunology.

Evaluation of autoantibodies as predictors of treatment response and immune‐related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan‐cancer study

A. Gerger, G. Absenger, J. Szkandera, 2022, Cancer medicine.

Preoperative fibrinogen/CRP score predicts survival in upper urothelial tract carcinoma patients undergoing radical curative surgery

M. Pichler, R. Zigeuner, G. Hutterer, 2023, World Journal of Urology.

Symptom clusters associated with complementary and alternative medicine use by cancer patients: A cross-sectional study

A. Terbuch, D. Jahn-Kuch, Jasmin Spiegelberg, 2023, PloS one.